羚锐制药：2025年半年度归属于上市公司股东的净利润同比增长14.85%

Core Insights - The company reported a revenue of 2,099,205,515.81 yuan for the first half of 2025, reflecting a year-on-year growth of 10.14% [2] - The net profit attributable to shareholders reached 474,385,806.53 yuan, marking a year-on-year increase of 14.85% [2] Financial Performance - Revenue for the first half of 2025: 2,099.21 million yuan, up 10.14% compared to the previous year [2] - Net profit for the same period: 474.39 million yuan, an increase of 14.85% year-on-year [2]